De Ruysscher D - Search Results

1

Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review.

Käsmann L, Dietrich A, Staab-Weijnitz CA, Manapov F, Behr J, Rimner A, Jeremic B, Senan S, De Ruysscher D, Lauber K, Belka C. Käsmann L, et al. Among authors: de ruysscher d. Radiat Oncol. 2020 Sep 10;15(1):214. doi: 10.1186/s13014-020-01654-9. Radiat Oncol. 2020. PMID: 32912295 Free PMC article. Review.

2

Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer.

Senan S, De Ruysscher D, Giraud P, Mirimanoff R, Budach V; Radiotherapy Group of European Organization for Research and Treatment of Cancer. Senan S, et al. Among authors: de ruysscher d. Radiother Oncol. 2004 May;71(2):139-46. doi: 10.1016/j.radonc.2003.09.007. Radiother Oncol. 2004. PMID: 15110446 Review.

3

Critical review of PET-CT for radiotherapy planning in lung cancer.

Senan S, De Ruysscher D. Senan S, et al. Among authors: de ruysscher d. Crit Rev Oncol Hematol. 2005 Dec;56(3):345-51. doi: 10.1016/j.critrevonc.2005.05.001. Epub 2005 Jun 28. Crit Rev Oncol Hematol. 2005. PMID: 15990331 Review.

4

Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.

De Ruysscher D, Dehing C, Bremer RH, Bentzen SM, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M, Dingemans AM, Boersma L, van Haren E, Geraedts W, Pitz C, Simons J, Wouters B, Rosier JF, Lambin P. De Ruysscher D, et al. Ann Oncol. 2007 May;18(5):909-16. doi: 10.1093/annonc/mdm005. Epub 2007 Feb 23. Ann Oncol. 2007. PMID: 17322546 Free article.

5

HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.

De Ruysscher D, Wanders R, van Haren E, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P. De Ruysscher D, et al. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. doi: 10.1016/j.ijrobp.2007.09.048. Epub 2007 Nov 26. Int J Radiat Oncol Biol Phys. 2008. PMID: 18037581 Clinical Trial.

6

Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study.

van Baardwijk A, Bosmans G, Boersma L, Wanders S, Dekker A, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1394-401. doi: 10.1016/j.ijrobp.2007.11.070. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258380

7

Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.

van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1103-10. doi: 10.1016/j.ijrobp.2007.11.028. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258382 Clinical Trial.

8

The importance of patient characteristics for the prediction of radiation-induced lung toxicity.

Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. Dehing-Oberije C, et al. Among authors: de ruysscher d. Radiother Oncol. 2009 Jun;91(3):421-6. doi: 10.1016/j.radonc.2008.12.002. Epub 2009 Jan 13. Radiother Oncol. 2009. PMID: 19147245

9

Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.

De Ruysscher D, Houben A, Aerts HJ, Dehing C, Wanders R, Ollers M, Dingemans AM, Hochstenbag M, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Radiother Oncol. 2009 Jun;91(3):415-20. doi: 10.1016/j.radonc.2009.01.004. Epub 2009 Feb 3. Radiother Oncol. 2009. PMID: 19195730

10

High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL.

Pijls-Johannesma M, Houben R, Boersma L, Grutters J, Seghers K, Lambin P, Wanders R, De Ruysscher D. Pijls-Johannesma M, et al. Among authors: de ruysscher d. Radiother Oncol. 2009 Jun;91(3):443-8. doi: 10.1016/j.radonc.2009.02.010. Epub 2009 Mar 16. Radiother Oncol. 2009. PMID: 19297049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page